Description
Reg. No. G2295 (Act 36/1947)
Namibia Reg. No. V97/24.5/832 NS0
This vaccine may only be used by or under the supervision of persons registered in terms of or authorised in terms of section 23 (1) (c) of the Veterinary and Para-Veterinary Professions Act, 1982 (Act 19 of 1982).
INDICATIONS
Porcilis® APP is indicated for the active immunisation of weaner pigs as an aid in the control of pleuropneumonia caused by Actinobacillus pleuropneumoniae.
COMPOSITION
The vaccine is based on an outer membrane protein (OMP) and three toxoids (detoxified APX I, APX II and APX III) produced by Actinobacillus pleuropneumoniae strains. Each dose of vaccine contains 50 units APX I, 50 units APX II, 50 units APX III and 50 units OMP as the active ingredients. The antigens are suspended in an aqueous adjuvant. Porcilis® APP contains 0,02 % formaldehyde as a preservative.